
What Happened to Lead Levels After Long-Term IV Chelation Therapy?
A study by Dr. Stephen Petteruti found that all participants had lower provoked urinary lead levels after intermittent calcium EDTA-based IV chelation therapy.
Dr. Stephen Petteruti is a physician focused on strategic prostate cancer care and men’s health. Author of Fight Cancer Like a Man, he teaches men how to assess risk, think long term, and protect quality of life before making irreversible decisions.
Live Last read · last published · next check

A study by Dr. Stephen Petteruti found that all participants had lower provoked urinary lead levels after intermittent calcium EDTA-based IV chelation therapy.

What Chris Holmes and Montell Jordan’s prostate cancer stories reveal about treatment, active surveillance, and Dr. Petteruti’s active management approach.
The Gleason score plays a significant role in guiding prostate cancer treatment decisions. However, questions remain regarding its reliability and the limitations of the information it provides.

The EpiSwitch PSE test is gaining attention. Here’s what the research shows, what the numbers mean, and how it fits into prostate monitoring.

In my published pilot study, 10 patients received calcium EDTA-based chelation therapy. Each patient demonstrated a reduction in coronary artery calcium score.

The books I recommend will help you understand your diagnosis, ask better questions, and make informed decisions.

Help us reach more men with trusted health education while earning exclusive member rewards.

Sexual performance isn't just about sex. It's often one of the earliest signs your health is changing.
Why Radiation Became the Default Recommendation
Many men diagnosed with prostate cancer will never be harmed by it.